Biosensors,
Journal Year:
2023,
Volume and Issue:
13(3), P. 346 - 346
Published: March 4, 2023
With
the
increasing
number
of
patients
suffering
from
Parkinson's
disease,
importance
measuring
drug
levels
in
patient
body
fluids
has
increased
exponentially,
particularly
for
clozapine.
There
is
a
growing
demand
real-time
analysis
biofluids
on
single
low-cost
platform
ultra-low
fluid
volumes
with
robustness.
This
study
aims
to
measure
level
clozapine
(Clz)
portable
potentiostat
using
practical
approach.
For
this
purpose,
we
developed
an
inexpensive,
via
electrochemistry
commercial
glucose
test
strip
(CTS).
CTSs
were
first
modified
by
removing
enzyme
mixture
surface
sensing
zone,
which
was
followed
modification
Multi
walled
carbon
nanotube
(MWCNT)
and
Nafion.
The
electrochemical
characteristics
CTS
electrodes
investigated
cyclic
voltammetry
(CV)
differential
(DPV)
techniques.
designed
sensor
displayed
decent
linear
range,
detection
limit,
reproducibility,
reusability
results.
A
dynamic
range
0.1-5
μM
observed
under
optimized
conditions
good
sensitivity
(1.295
μA/μM)
limit
(83
nM).
Furthermore,
electrode
used
amount
Clz
real
samples.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(4), P. 453 - 453
Published: April 3, 2023
Electrochemical
sensors
consisting
of
screen-printed
electrodes
(SPEs)
are
recurrent
devices
in
the
recent
literature
for
applications
different
fields
interest
and
contribute
to
expanding
electroanalytical
chemistry
field.
This
is
due
inherent
characteristics
that
can
be
better
(or
only)
achieved
with
use
SPEs,
including
miniaturization,
cost
reduction,
lower
sample
consumption,
compatibility
portable
equipment,
disposability.
SPEs
also
quite
versatile;
they
manufactured
using
formulations
conductive
inks
substrates,
varied
designs.
Naturally,
analytical
performance
directly
affected
by
quality
material
used
printing
modifying
electrodes.
In
this
sense,
most
carbon
nanomaterials
have
been
explored
preparation
modification
providing
an
enhanced
electrochemical
response
greater
sensitivity,
addition
functionalized
surfaces
immobilize
biological
agents
manufacture
biosensors.
Considering
relevance
timeliness
topic,
review
aimed
provide
overview
current
scenario
carbonaceous
context
making
SPE
sensors,
from
which
approaches
will
presented,
exploring
materials
traditionally
investigated
electrochemistry,
such
as
graphene,
nanotubes,
black,
those
more
recently
(carbon
quantum
dots,
graphitic
nitride,
biochar).
Perspectives
on
expansion
these
considered.
ECS Sensors Plus,
Journal Year:
2024,
Volume and Issue:
3(1), P. 011601 - 011601
Published: March 1, 2024
There
is
a
plethora
of
electrochemical
biosensors
developed
for
ultrasensitive
detection
clinically
relevant
biomarkers.
However,
many
these
systems
lose
their
performance
in
heterogeneous
clinical
samples
and
are
too
complex
to
be
operated
by
end
users
at
the
point-of-care
(POC),
prohibiting
commercial
success.
Integration
with
sample
processing
technology
addresses
both
challenges;
however,
it
adds
manufacturing
complexity
overall
cost
systems.
Herein,
we
review
different
components
biosensor
avenues
creating
fully
integrated
In
context
integration,
focus
on
discussing
trade-offs
between
sensing
performance,
cost,
scalable
guide
readers
toward
designing
new
commercialization
potential.
Biosensors,
Journal Year:
2023,
Volume and Issue:
13(2), P. 211 - 211
Published: Jan. 31, 2023
Catecholamines,
including
dopamine,
epinephrine,
and
norepinephrine,
are
considered
one
of
the
most
crucial
subgroups
neurotransmitters
in
central
nervous
system
(CNS),
which
they
act
at
brain’s
highest
levels
mental
function
play
key
roles
neurological
disorders.
Accordingly,
analysis
such
catecholamines
biological
samples
has
shown
a
great
interest
clinical
pharmaceutical
importance
toward
early
diagnosis
diseases
as
Epilepsy,
Parkinson,
Alzheimer
diseases.
As
promising
routes
for
real-time
monitoring
catecholamine
neurotransmitters,
optical
electrochemical
biosensors
have
been
widely
adopted
perceived
dramatically
accelerating
development
last
decade.
Therefore,
this
review
aims
to
provide
comprehensive
overview
on
recent
advances
main
challenges
biosensors.
Particular
emphasis
is
given
biosensors,
reviewing
their
sensing
mechanism
unique
characteristics
brought
by
emergence
nanotechnology.
Based
specific
biosensors’
performance
metrics,
multiple
perspectives
therapeutic
use
nanomaterial
future
trends
also
summarized.
RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(38), P. 27957 - 27971
Published: Jan. 1, 2024
Disposable
adlayer
modified
screen-printed
electrodes
have
become
extremely
useful
devices
for
ensuring
food
safety
and
quality
assessment
because
of
their
adaptability,
affordability,
convenience
use.
Frontiers in Medical Technology,
Journal Year:
2024,
Volume and Issue:
6
Published: Feb. 15, 2024
Herein,
advancements
in
electroanalytical
devices
for
the
simultaneous
detection
of
diverse
breast
cancer
(BC)
markers
are
demonstrated.
This
article
identifies
several
important
areas
exploration
electrochemical
diagnostics
and
highlights
factors
that
pivotal
successful
deployment
novel
bioanalytical
devices.
We
have
highlighted
limits
(LOD)
reported
multiplex
biosensor
can
surpass
sensitivity
displayed
by
current
clinical
standards
such
as
ELISA,
FISH,
PCR.
HER-2;
a
marker
characterised
increased
metastatic
potential,
more
aggressive
development,
poor
outcomes;
be
sensed
with
LOD
0.5
ng/ml
using
platforms,
which
falls
within
range
measured
ELISA
(from
picogram/ml
to
nanogram/ml).
Electrochemical
biosensors
0.53
0.21
U/ml
MUC-1
CA
15-3,
respectively,
or
5.8
×
10
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
6(2)
Published: Jan. 31, 2024
Abstract
Electrochemical
biosensors
fabricated
based
on
nucleic
acids
have
shown
great
potential
for
cancer
recognition
because
of
their
low
cost,
fast
feedback,
high
sensitivity,
and
easy
operation.
This
review
will
demonstrate
the
impression
recent
advances
applications
electrochemical
that
are
acid-based
detection.
We
compare
formulated
with
those
formed
antibodies
highlight
some
examples
developed
detection,
such
as
use
DNA
or
RNA
aptamers
to
detect
prostate-specific
antigens,
microRNA-21,
carcinoembryonic
antigens.
discuss
rewards
drawbacks
these
challenges
they
face,
stability,
reproducibility,
interference,
standardization.
also
suggest
possible
directions
opportunities
future
research
development,
developing
novel
acid
elements,
exploring
new
transducer
materials
configurations,
designing
signal
amplification
strategies,
integrating
microfluidic
devices
portable
instruments,
evaluating
in
clinical
settings
actual
samples
from
patients
healthy
donors.
Overall,
we
believe
offer
an
auspicious
alternative
conventional
methods
detection
contribute
early
diagnosis
effective
treatment.
Graphical